In the recent issue of International Biopharmaceutical Journal, our client examines the breadth of claims that might be obtained in different circumstances based on current European Patent Office practice, and considers when questions of lack of enablement are most likely to arise in an antibody case.

Our client looks here at “Securing IP protection in machine learning techniques for fintech businesses” in The Patent Magazine. As Fintech places particular demands on high frequency computing (HFC) and requires significant investment into computing resources and manpower, machine learning  is increasing with supervised models trained on input data sets that have known outcomes and […]

The government recently announced new sanctions under the global human rights regime, freezing UK assets of those named and banning them from entering the country. The legislation gives the UK new powers to stop those involved laundering money through UK banks and those guilty of human rights abuses from entering the UK. Our client comments […]

The coronavirus pandemic and lockdown have stress-tested employment contracts and policies, with some showing signs of strain.  Our client’s article in The Lawyer Monthly examines how businesses and employers can make sure their employment documentation is ready for the post-Covid future.

Developments in artificial intelligence (AI) and machine learning (ML) are playing an increasingly influential role in the pharma sector. Our client provides an overview of developments in the AI healthcare sector which include overcoming the legal, regulatory and commercial hurdles in this high growth area.

Our client, leading Intellectual Property firm Mathys & Squire, has now launched an initiative called Scaleup Quarter, specifically aimed at growing businesses and entrepreneurs to build a community where businesses, individuals, investors, supporters and advisers can come together to connect around all IP matters. As IP only makes up one part of a scaleup’s journey, […]